FDA Inspection
Tianjin Kingyork Pharmaceuticals Co., LtdTianjin Kingyork Pharmaceuticals Co., Ltd – FDA Inspection, Jul 26, 2024
Record Details
This FDA Inspection record concerns Tianjin Kingyork Pharmaceuticals Co., Ltd, with an inspection on July 26, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 05774bd5-a7e4-4adb-8eee-aebeedea48d3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1246994
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Tianjin Kingyork Pharmaceuticals Co., Ltd
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 31, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| August 27, 2019 | Not classified | Office of Inspections and Investigations | |
| May 31, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 29, 2018 | Not classified | Office of Inspections and Investigations | |
| September 1, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Tianjin Kingyork Pharmaceuticals Co., Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.